Last reviewed · How we verify
non-RAS inhibitor antihypertensive therapy
non-RAS inhibitor antihypertensive therapy is a Non-RAS inhibitor antihypertensive Small molecule drug developed by Mario Negri Institute for Pharmacological Research. It is currently in Phase 3 development for Hypertension.
Non-RAS inhibitor antihypertensive therapy works by blocking the action of certain natural chemicals in the body that cause blood vessels to constrict, leading to a decrease in blood pressure.
Non-RAS inhibitor antihypertensive therapy works by blocking the action of certain natural chemicals in the body that cause blood vessels to constrict, leading to a decrease in blood pressure. Used for Hypertension.
At a glance
| Generic name | non-RAS inhibitor antihypertensive therapy |
|---|---|
| Sponsor | Mario Negri Institute for Pharmacological Research |
| Drug class | Non-RAS inhibitor antihypertensive |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
Non-RAS inhibitors are a class of antihypertensive drugs that target various pathways to lower blood pressure. They do not inhibit the renin-angiotensin-aldosterone system (RAS), which is targeted by other antihypertensive drugs. Instead, they work through different mechanisms to relax blood vessels and improve blood flow.
Approved indications
- Hypertension
Common side effects
- Headache
- Dizziness
- Fatigue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- non-RAS inhibitor antihypertensive therapy CI brief — competitive landscape report
- non-RAS inhibitor antihypertensive therapy updates RSS · CI watch RSS
- Mario Negri Institute for Pharmacological Research portfolio CI
Frequently asked questions about non-RAS inhibitor antihypertensive therapy
What is non-RAS inhibitor antihypertensive therapy?
How does non-RAS inhibitor antihypertensive therapy work?
What is non-RAS inhibitor antihypertensive therapy used for?
Who makes non-RAS inhibitor antihypertensive therapy?
What drug class is non-RAS inhibitor antihypertensive therapy in?
What development phase is non-RAS inhibitor antihypertensive therapy in?
What are the side effects of non-RAS inhibitor antihypertensive therapy?
Related
- Drug class: All Non-RAS inhibitor antihypertensive drugs
- Manufacturer: Mario Negri Institute for Pharmacological Research — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Hypertension
- Compare: non-RAS inhibitor antihypertensive therapy vs similar drugs
- Pricing: non-RAS inhibitor antihypertensive therapy cost, discount & access